OneDigital Investment Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $392K | Buy |
628
+100
| +19% | +$68.1K | ﹤0.01% | 1152 |
|
|
2026
Q1 | $408K | Sell |
528
-41
| -7% | -$31.4K | ﹤0.01% | 1026 |
|
|
2025
Q4 | $439K | Buy |
569
+38
| +7% | +$25.8K | ﹤0.01% | 1006 |
|
|
2025
Q3 | $299K | Sell |
531
-52
| -9% | -$29.4K | ﹤0.01% | 1186 |
|
|
2025
Q2 | $306K | Buy |
583
+39
| +7% | +$21.8K | ﹤0.01% | 1155 |
|
|
2025
Q1 | $345K | Sell |
544
-418
| -43% | -$288K | ﹤0.01% | 1022 |
|
|
2024
Q4 | $685K | Sell |
962
-44
| -4% | -$36.9K | 0.01% | 768 |
|
|
2024
Q3 | $1.06M | Sell |
1,006
-4
| -0.4% | -$4.45K | 0.01% | 636 |
|
|
2024
Q2 | $1.06M | Buy |
1,010
+181
| +22% | +$175K | 0.01% | 596 |
|
|
2024
Q1 | $798K | Buy |
829
+354
| +75% | +$337K | 0.01% | 577 |
|
|
2023
Q4 | $417K | Buy |
475
+49
| +12% | +$40.4K | 0.01% | 779 |
|
|
2023
Q3 | $351K | Sell |
426
-155
| -27% | -$122K | 0.01% | 754 |
|
|
2023
Q2 | $418K | Sell |
581
-37
| -6% | -$28.5K | 0.01% | 703 |
|
|
2023
Q1 | $508K | Sell |
618
-71
| -10% | -$53.5K | 0.01% | 614 |
|
|
2022
Q4 | $497K | Sell |
689
-295
| -30% | -$218K | 0.01% | 520 |
|
|
2022
Q3 | $678K | Buy |
984
+623
| +173% | +$392K | 0.03% | 383 |
|
|
2022
Q2 | $213K | Sell |
361
-11
| -3% | -$7.15K | 0.01% | 645 |
|
|
2022
Q1 | $260K | Sell |
372
-2
| -0.5% | -$1.26K | 0.01% | 640 |
|
|
2021
Q4 | $236K | Sell |
374
-3
| -0.8% | -$1.84K | 0.01% | 669 |
|
|
2021
Q3 | $228K | Sell |
377
-30
| -7% | -$18.6K | 0.01% | 647 |
|
|
2021
Q2 | $227K | Buy |
+407
| New | +$206K | 0.01% | 641 |
|
|
2021
Q1 | – | Sell |
-594
| Closed | -$287K | – | 754 |
|
|
2020
Q4 | $287K | Buy |
594
+137
| +30% | +$74K | 0.01% | 503 |
|
|
2020
Q3 | $256K | Buy |
+457
| New | +$277K | 0.02% | 479 |
|
|
2019
Q3 | – | Sell |
-294
| Closed | -$92K | – | 1020 |
|
|
2019
Q2 | $92K | Buy |
294
+205
| +230% | +$68.2K | 0.01% | 471 |
|
|
2019
Q1 | $37K | Sell |
89
-10
| -10% | -$4.12K | 0.01% | 558 |
|
|
2018
Q4 | $37K | Buy |
+99
| New | +$36.2K | 0.01% | 517 |
|
|
2018
Q3 | – | Sell |
-201
| Closed | -$69K | – | 1170 |
|
|
2018
Q2 | $69K | Sell |
201
-4
| -2% | -$1.25K | 0.01% | 418 |
|
|
2018
Q1 | $71K | Buy |
205
+90
| +78% | +$31.3K | 0.02% | 430 |
|
|
2017
Q4 | $43K | Sell |
115
-10
| -8% | -$4.05K | ﹤0.01% | 555 |
|
|
2017
Q3 | $56K | Sell |
125
-6
| -5% | -$2.85K | 0.02% | 361 |
|
|
2017
Q2 | $64K | Buy |
+131
| New | +$57.3K | 0.02% | 412 |
|
Other funds holding REGN
OneDigital Investment Advisors's REGN Position: Q2 2026 in Review
OneDigital Investment Advisors increased its Regeneron Pharmaceuticals (REGN) stake by 19% in Q2 2026, buying an estimated $68.1K and bringing the position to 628 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #1152.
OneDigital Investment Advisors first reported a position in REGN in Q2 2017 and has held it in 31 quarters since. The position peaked at $1.06M in Q2 2024. 789 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- OneDigital Investment Advisors held 628 shares of Regeneron Pharmaceuticals worth $392K as of Q2 2026.
- OneDigital Investment Advisors bought 100 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $68.1K.
- Regeneron Pharmaceuticals made up ﹤0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #1152 holding.
- OneDigital Investment Advisors first reported a position in Regeneron Pharmaceuticals in Q2 2017 and has held it in 31 quarters since.
- OneDigital Investment Advisors's Regeneron Pharmaceuticals position peaked at $1.06M in Q2 2024.
- 789 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.